At 5.8% CAGR, the North America Microbial Identification Methods Market is Projected to be Worth US$ 3,319.78 Million by 2030, Says Business Market Insights

According to Business Market Insights research, the North America microbial identification methods market was valued at US$ 2,111.83 in 2022 and is expected to reach US$ 3,319.78 million by 2030, registering a CAGR of 5.8% from 2022 to 2030. Government initiatives and funding to promote microbial identification and increasing food safety concerns demanding for microbial identification procedure are among the critical factors attributed to the North America microbial identification methods market expansion.

Government initiatives and funding promoting microbial identification are crucial pillars of public health, scientific research, and industrial development. These initiatives serve a wide range of purposes, from enhancing disease surveillance and response to supporting innovative research in microbiology. For instance, in March 2023, the American Society for Microbiology (ASM) requested that Congress issue at least $ 50.924 billion for the National Institutes of Health (NIH) and $ 11.58 billion for the Centers for Disease Control and Prevention (CDC) in FY 2024. ASM requested $ 175 million within the CDC budget for the Advanced Molecular Detection (AMD) program in the National Center for Emerging and Zoonotic Infectious Diseases. Moreover, governments fund academic research through grants and institutions to foster breakthroughs in microbial identification, benefiting fields such as biotechnology, pharmaceuticals, and environmental sciences. These investments also bolster food safety and agricultural practices by supporting research to detect foodborne pathogens. Furthermore, governments often collaborate with private enterprises, creating public-private partnerships that drive innovation in microbial identification technologies. Overall, these initiatives and funding mechanisms play a pivotal role in safeguarding public health, advancing scientific knowledge, and driving economic growth by underpinning the microbial identification field.

On the contrary, high cost of automated microbial identification systems hampers the growth North America microbial identification methods market.

Based on method, the North America microbial identification methods market is segmented into genotypic, phenotypic, and proteotypic. The phenotypic segment held 53.3% share of the North America microbial identification methods market in 2022, amassing US$ 1,124.76 million. It is projected to garner US$ 1,705.97 million by 2030 to expand at 5.3% CAGR during 2022-2030. The genotypic segment is further subsegmented into instruments, kits, reagents. The phenotypic segment is further subsegmented into instruments, kits, reagents. The proteotypic segment is further subsegmented into instruments, kits, reagents.

By type, the North America microbial identification methods market is segmented into bacterial identification system, microbial enumeration system, bacterial resistance identification systems, microbiology analyzer, and others. The bacterial identification system segment held 37.7% share of the North America microbial identification methods market in 2022, amassing US$ 797.19 million. It is projected to garner US$ 1,342.91 million by 2030 to expand at 6.7% CAGR during 2022-2030.

Based on country, the North America microbial identification methods market is bifurcated into the US and Canada. The US held 92.2% share of North America microbial identification methods market in 2022, amassing US$ 1,947.96 million. It is projected to garner US$ 3,099.35 million by 2030 to expand at 6.0% CAGR during 2022-2030.

Key players operating in the North America microbial identification methods market are Accelerate Diagnostics Inc, Avantor Inc, Becton Dickinson and Co, bioMérieux SA, Bruker Corp, Danaher Corp, Merck KGaA, Molzym GmbH & Co KG, Shimadzu Corp, Thermo Fisher Scientific Inc, among others.